Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1820-1824

  Nakata, B ^a   Hirakawa, K ^a   Chung, Y S ^a   Kato, Y ^a   Yamashita, Y ^a   Inui, A ^a   Arimoto, Y ^a   Maeda, K ^a   Onoda, N ^a   Sawada, T ^a   Sowa, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbohydrate antigen 19 9; Carcinoembryonic antigen; Gastric cancer; Monocyte; Prognosis; Soluble interleukin 2 receptor

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 2 RECEPTOR; TUMOR MARKER;

ARTICLE; BLOOD CELL COUNT; BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCYTE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

EID: 0031750176     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.302     Document Type: Article

References (33)

1. Ambrosetti A, Nadali G, Vinante F, Carlini S, Veneri D, Todeschini G, Morosato L, de Sabata D, Chilosi M, Maggi E, Parronchi P, Romagnani S, Semenzato G, Perona G and Pizzolo G (1993) Serum levels of soluble interleukin-2 receptor in Hodgkin's disease. Relationship with clinical stage, tumor burden, and treatment outcome. Cancer 72: 201-206
2. Barton DP, Blanchard DK, Michelini Norris B, Nicosia SV, Cavanagh D and Djeu JY (1993) High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood 81: 424-429
3. Barton DP, Blanchard DK, Wells AF, Nicosia SV, Roberts WS, Cavanagh D and Djeu JY (1994) Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer. Anticancer Res 14: 761-772
4. Berghella AM, Pellegrini P, Piancatelli D, Maccarone D, Del Beato T, Giubilei D, Pomidori A, Adorno D and Casciani CU (1994) Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations. Cancer Immunol Immunother 38: 160-166
5. Brown AE, Rieder KT and Wehster HK (1989) Prolonged elevation of soluble interleukin-2 receptors in tuberculosis. Am Rev Respir Dis 139: 1036-1038
6. Buccheri G, Marino P, Preatoni A, Ferrigno D and Moroni GA (1991) Soluble interleukin 2 receptor in lung cancer. An indirect marker of tumor activity? Chest 99: 1433-1437
7. Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P and Facchini V (1994) Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer. Gynecol Oncol 52: 386-391
8. Gold P and Freedman SO (1965) Demonstration of tumor-specific antigens in human colonie carcinoma by immunological tolerance and adsorption techniques. J Exp Med 121: 439-162
9. Holter W, Goldman CK, Casabo L, Nelson DL, Greene WC and Waldmann TA (1987) Expression of functional IL-2 receptors by lipopolysaccharide and interferon-γ human monocytes. J Immunol 138: 2917-2922
10. Japanese Research Society for Gastric Cancer (1995) Japanese Classification of Gastric Carcinoma. First English Edition. Kanehara: Tokyo
11. Koprowski U, Herlyn M, Steplewski Z and Sears HF (1981) Specific antigen in serum of patients with colon carcinoma. Science 212: 53-55
12. Lai KN, Ho S, Leung JC and Tsao SY (1991) Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma. Cancer 67: 2180-2185
13. Lissoni P, Barni S, Rovelli F, Viviani S, Maestroni GJM, Conti A and Tancini G (1990) The biological significance of soluble interleukin-2 receptors in solid tumors. Eur J Cancer 26: 33-36
14. Murakami S, Satomi A, Ishida K, Murai H and Okamura Y (1994a) Serum soluble interleukin-2 receptor in colorectal cancer. Acta Oncol 33: 19-21
15. Murakami S, Satomi A, Ishida K, Murai U, Matsuki M and Hashimoto T (1994b) Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer. Cancer 74: 2745-2748
16. O'Garra A (1989) Interleukins and the immune system. Lancet 1: 943-947
17. Pizzolo G, Vincenzi C, Vinante F, Rigo A, Veneri D, Chilosi M, Dusi S, Poli G, Zambello R, Semenzato G and Berton G (1992) Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro. Cell Immunol 141: 253-259
18. Poulakis N, Sarandakou A, Rizos D, Phocas I, Kontozoglou T and Polyzogopoulos D (1991) Soluble interleukin-2 receptors and other markers in primary lung cancer. Cancer 68: 1045-1049
19. Rand TH, Silberstein DS, Kornfeld H and Weller PF (1991) Human eosinophils express functional interleukin 2 receptors. J Clin Invest 88: 825-832
20. Rubin LA and Nelson DL (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 133: 619-627
21. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R and Nelson DL (1985) Soluble interleukin 2 receptors are released by activated human lymphoid cells in vitro. J Immunol 135: 3172-3176
22. Rubin LA, Jay G and Nelson DL (1986) The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 137: 3841-3844
23. Sharma S, Saha K, Shinghal RN and Malik GD (1991) Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumour. Cancer Immunol Immunother 33: 198-202
24. Symons JA, Wood NC, Giovine FS and Duff GW ( 1988) Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 141: 2612-2618
25. Takeshita T, Goto Y, Tada K, Nagata K, Asano H and Sugamura K (1989) Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med 169: 1323-1332
26. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M and Sugamura K (1992) Cloning of the γ-chain of the human IL-2 receptor. Science 257: 379-382
27. Taniguchi T and Minami Y (1993) The IL2/IL2 receptor system: a current overview. Cell 73: 5-8
28. Tartour E, Deneux L, Mosseri V, Jaulerry C, Brunin F, Point D, Validire P, Dubray B, Fridman WH and Rodriguez J (1997) Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma. Cancer 79: 1401-1408
29. Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H and Uchino H (1985) Interleukin-2 receptor (Tac Antigen) expressed on adult T cell leukemia cells. J Clin Invest 76: 446-453
30. Waldmann TA, Goldmann CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ and Greene WC (1984) Expression of interleukin 2 receptors on activated human B cells. J Exp Med 160: 1450-1466
31. Wang YF, Wu XN, Zhou YH, Chen XF, Shen J and Wang HJ (1994) Clinical significance of elevated serum soluble interleukin-2 receptor in gastric cancer. Chin Med J Engl 107: 254-256
32. Yamaguchi S, Onji M and Ohta Y (1988) Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases. Hepato-Gastroenterol 35: 245-248
33. Yasumura S, Lin W, Weidmann E, Hebda P and Whiteside TL (1994) Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. Int J Cancer 59: 225-234